Skip to main content

Rejected Blood Samples: Recollection Calls and Follow-Through

When a laboratory requests recollection, confirm the affected specimen, investigation and stated reason, then obtain the clinical and collection plan before calling the patient. Explain the confirmed facts in neutral language, acknowledge the inconvenience and specify the next arrangement, including any unresolved charge. A rejected sample is not a normal result. Keep the original request, rejection and replacement specimen linked until the investigation and patient follow-through are resolved.

By Bractis · Updated · 15 min read

Indian clinic teams handling haemolysed, clotted, insufficient or incorrectly identified specimens and arranging repeat collection.

Find out exactly what the laboratory could not report

A message saying “sample haemolysed” does not establish that every investigation on the request is unavailable. Ask which specimen and tests are affected, whether any results were released, and what the laboratory recommends for the remaining work. Preserve its actual wording and report or accession reference.

Haemolysis, clotting, insufficient quantity and identification discrepancies are different categories. Their suitability implications depend on the investigation and laboratory procedure. Do not apply a universal threshold from an unrelated analyser or assume that one rejected component invalidates every other reported result.

WHO’s LQSI activities describe laboratory-defined sample acceptance criteria and a rejection record linking the patient, specimen, requester, dates and reason. These are quality-management aids. They do not supply a universal acceptance threshold, an Indian legal rule or a clinical decision for an individual patient.

Source: WHO LQSI: Sample acceptance and rejection criteria

Source: WHO LQSI: Sample rejection procedure and notification form

Ask what the delay means for this patient

The ordering doctor needs to know that the intended information is unavailable or qualified. The clinical response may depend on why the test was requested and the patient’s current circumstances. Reception should not independently decide that recollection can wait until the next routine visit.

If some results are available, route them with the rejection notice so the doctor sees the complete situation. Avoid a summary that says “all results received” because a PDF exists. A partially reported request still needs a decision about its missing components.

Document the chosen next step and coverage if the doctor is absent. A new collection booking is one operational action; it does not itself establish that the clinical consequences of delay have been assessed.

Worked case: one rejected specimen leaves one investigation outstanding

Fictional case R-74 concerns one clinic request O16 for investigations A, B and C. These letters are teaching labels, not a recommended test panel. The original collection produced two separately identified containers: C11 for A and B, and C12 for C. At 08:30 on 28 October 2026, the laboratory releases reports for A and B from accepted specimen C11. It reports that C12 has insufficient material for C under its applicable procedure, so no C result is available.

The first task is to establish that scope. “Sample rejected” on an inbox row is too broad: there are two released results, one unreported investigation and one rejected specimen. Retain the laboratory’s notice and its request/specimen references. A document labelled “final” for the work reported on that document would not, by itself, answer whether all three investigations on O16 have been completed. Nor should an empty C result be converted into a normal value or a zero.

At 08:45, an accepted covering clinician reviews the available reports and missing-information notice, records the patient-specific plan and authorises the next contact. The example does not disclose a diagnosis, clinical urgency or treatment decision. Those must be assessed for the actual patient. Reception can coordinate the agreed next step, but a booking should not silently replace the clinician’s assessment of the missing information.

The plan eventually leads to a replacement container C13 for C, linked to O16 and rejected C12. No repeat of A or B is assumed. A replacement might have a new laboratory accession or require another administrative request under the receiving service’s process; that does not create a new clinical indication by itself. Keep the relationship explicit so the later report is attributed to the new specimen and actual collection time, not backdated to C12.

On a narrow screen, scroll the table horizontally to read all columns.

Fictional R-74 at 13:00: two reported investigations and one still outstanding
Requested workSpecimen relationshipEvidence and remaining action
AOriginal C11 accepted and usedReport released at 08:30; review documented at 08:45
BOriginal C11 accepted and usedReport released at 08:30; review documented at 08:45
COriginal C12 rejected; replacement C13 received and accepted at 12:40No result at 13:00; accepted covering clinician retains result follow-through

Prepare the call so the patient receives a usable answer

Before calling, know the approved collection arrangement, what preparation needs reconfirmation, who will pay under the actual service agreement and whom the patient can contact with a clinical concern. If any item is unresolved, say so clearly and assign someone to obtain the answer.

Confirm that the recipient is the patient or an appropriate authorised contact. Shared family phones are common enough to require care, but the caller should not assume that whoever answers can receive test details. Ask for a suitable conversation before explaining sensitive information.

Use the patient’s preferred language and distinguish the sample problem from a diagnosis. “The laboratory could not complete this investigation with that specimen” may be accurate; “your blood is bad” is misleading and alarming. Do not invent a cause to make the explanation sound complete.

Match the explanation to the confirmed reason

The table offers communication boundaries, not laboratory acceptance criteria. Use the specific explanation confirmed by the laboratory. If the cause is still being investigated, separate that uncertainty from the practical plan for the patient.

An apology for inconvenience does not require guessing who caused the problem. The clinic can acknowledge another journey, lost time or discomfort while investigating the process accurately.

On a narrow screen, scroll the table horizontally to read all columns.

Explaining recollection without adding unsupported conclusions
Laboratory messageUseful explanationAvoid saying
Haemolysis affects specified testingThe laboratory cannot use this specimen for the named investigationThe result is normal, or every test is necessarily invalid
Clotted specimen for affected testThe sample condition prevents the requested analysis under its procedureThe patient has a clotting disorder because the tube clotted
Insufficient specimenThe available quantity was not adequate for the specified workThe collector is at fault before the event is reviewed
Identification discrepancyThe laboratory cannot confidently match the specimen as requiredStaff can safely guess the identity and relabel it
Unclear rejection noticeThe clinic is confirming the exact issue and next arrangementA fabricated explanation or unsupported reassurance

Use a short script with room for the actual situation

This is an original communication template to adapt after the clinical and laboratory decisions are known. It is not a promise of a free repeat, a fixed deadline or a guarantee that the next sample will be accepted.

Invite the patient to explain practical difficulties. A person who travelled from a village or took unpaid leave may need coordination with a nearer collection site. Any alternative site must be suitable for the investigation and agreed with the responsible team; convenience alone cannot establish equivalence.

Record what the call achieved when travel changes the plan

R-74’s first call reaches someone answering a shared household phone. Their authority to receive the patient’s investigation details is not established, so the caller records an unsuccessful patient-contact attempt without disclosing those details. That is not the same as refusal or nonattendance. At 09:20 the clinic reaches the patient through the agreed identity process. The patient explains that returning to the original collection point would mean another long journey and unpaid time away from work.

The useful response is to record the barrier and route it back to the responsible team. Do not relabel “cannot reach that site” as “declines all testing”, promise a nearer site before confirming it can handle the request, or decide from the reception desk that the investigation can wait. In this example the covering clinician reassesses the practical plan, and the laboratory confirms the alternative collection arrangement before it is offered as agreed. The clock times show the fictional sequence, not a safe waiting period for another patient.

During the agreed follow-up, the explanation distinguishes the sample issue from the patient’s health: the laboratory could not report C from C12; A and B were already reported; the responsible clinician has agreed the specific next step. Staff explain the confirmed location, preparation source and contact route in the patient’s preferred language and ask the patient to describe the arrangement back. Any unanswered preparation question returns to the clinical or laboratory owner rather than being filled with a generic fasting instruction.

The table follows this one case through contact and collection. A copy of the replacement request sent by message is not proof of attendance. The collection record for C13 is not proof of laboratory receipt. The later acceptance message is not a C result. Record the actual evidence at each stage, including which questions remain unanswered, so the next shift does not have to infer completion from the latest timestamp.

On a narrow screen, scroll the table horizontally to read all columns.

R-74 contact and recollection timeline — fictional times in IST
TimeActual eventBoundary preserved
08:30A/B reports and C12 rejection notice receivedC remains unreported; the request is only partly fulfilled
08:45Covering clinician reviews and records the initial planClinical responsibility accepted; subsequent access barriers may need reconsideration
09:00Household recipient cannot be confirmed as authorisedNo test details disclosed; patient contact not completed
09:20Patient reached; travel and work barrier explainedBarrier recorded rather than labelled refusal of all investigation
09:35Clinician reviews the barrier and seeks a workable arrangementA nearer collection point is still a proposal
10:10Lab confirms alternative site; clinician agrees and patient is informedActual instructions and understanding recorded; no universal preparation rule added
11:30C13 collected under the agreed arrangementNew specimen and actual collection time linked to C12/O16
12:40Laboratory confirms receipt and acceptance of C13C result and its clinical review still outstanding at the 13:00 cutoff

Resolve charges without making the patient repeat the dispute

Collection charges and laboratory fees may be handled by different organisations. Agree who will explain the financial arrangement and who has authority to waive or refund a charge. Do not promise a free repeat unless that arrangement is confirmed.

Keep the service-resolution record separate from the clinical result. A refund does not mean the investigation is complete, and a clinical need does not establish who was responsible for the specimen problem. The patient should have one named contact for unresolved billing questions.

Where a payment was already reconciled through cash or UPI, record any subsequent adjustment using the clinic’s normal financial process. Avoid collecting another payment simply because the software created a fresh order number for the replacement specimen.

Hand over the missing result, service question and cause investigation separately

At R-74’s 13:00 handover, the replacement has been accepted but C is still outstanding. Keep that clinical task with the accepted covering clinician and the clinic’s receipt-tracking arrangement. If the cover changes, arrange a new accepted handover. The fact that someone answered the call or that the laboratory accepted C13 does not remove the need to obtain and act on the eventual result through the actual clinical plan.

Two other streams remain open in this example: the service charge for recollection has not been confirmed, and the reason the original specimen quantity was inadequate is still under quality review. The stated laboratory rejection reason is known; the root cause and responsibility are not. The clinic’s billing contact handles the charge question, while the laboratory and collection service investigate the process. Neither unresolved stream should be silently substituted for the clinical decision about obtaining the missing information.

The record below deliberately ends before full resolution. It identifies three investigation components, three specimen identifiers over the episode, two initial reports and one outstanding result. There were two original containers and one replacement, not three separate clinical requests. The monthly eight-event denominator example later in this guide is a separate exercise; R-74 should not be added to that fictional cohort or used to claim a measured reduction in recollections.

If C later returns, retain the original rejection and replacement history while recording the actual result, review and patient follow-through. If the patient cannot complete another required step, record that circumstance and obtain the responsible clinician’s next decision. The aim is an accurate current plan with its evidence, not making every administrative status appear closed.

Review causes using clear denominators and unresolved cases

A recollection review should identify the unit being counted: specimens, patient encounters or requests. Record a primary reason for each event if calculating a breakdown, with additional contributing factors stored separately. Otherwise one event can inflate several categories.

Compare the recorded reason with the investigation outcome and process review. Repeated problems along one route may justify investigation, but a small count cannot establish individual blame. Use the laboratory’s quality process to determine corrective action and check whether the change actually helped.

Worked example: eight recollection events, with one reason per event

Fictional monthly review: eight specimen recollection events are assigned one primary reason each—three haemolysis, two clotting, one insufficient quantity and two identification discrepancies. The categories sum to eight. Haemolysis accounts for 3/8, or 37.5%, of these recollection events; it is not the clinic’s overall haemolysis rate because the total number of collected specimens has not been supplied. Two events also involved transport delays, recorded as additional factors rather than extra cases. The clinic investigates causes without claiming these figures are a benchmark.

Rejected Specimen and Recollection Worksheet

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Affected work
Which specimen and investigations were rejected, and which results remain usable or outstanding?
Clinical consequence
Who has assessed the delay and agreed the next patient-specific step?
Patient arrangement
Are location, preparation, communication language, access barriers and charges clear?
Completion evidence
Is the replacement linked to the original event, and has the resulting report received follow-through?

Questions doctors ask

Does a haemolysed sample mean the test result was normal?

No. It describes a specimen issue, whose effect on particular investigations must be determined by the laboratory. Keep any unavailable or qualified result distinct from a normal result and obtain the doctor’s plan.

Does a clotted sample mean the patient has a clotting disorder?

A specimen rejection message is not a diagnosis. Communicate the confirmed laboratory issue and let the responsible clinician assess the patient using appropriate evidence.

Must every investigation be repeated after one sample is rejected?

Confirm exactly which work is affected and what has already been reported. The laboratory and clinician should determine the remaining requirements rather than automatically repeating the whole request.

Should the clinic promise recollection will be free?

Only communicate a charge or waiver that has been confirmed under the actual clinic and laboratory arrangement. Assign a contact to resolve uncertainty and avoid making the patient negotiate between teams.

Can staff close the task after leaving a recollection message?

A message attempt does not establish that the patient understood or that the diagnostic plan is resolved. Record the contact outcome and hand the outstanding decision to an accepted owner.

Can a request have valid reports and still need recollection?

Yes. Establish which investigations the laboratory has reported, which specimen or work it rejected and what remains unavailable. Preserve existing source reports and obtain the responsible clinician’s plan for the missing information; do not automatically repeat every investigation or mark the entire request complete.

What if the patient cannot return to the original collection centre?

Record the practical barrier and refer it to the responsible clinician and laboratory. Confirm any alternative site, instructions and timing under the actual plan before promising the arrangement. Difficulty travelling to one location is not evidence that the patient refuses all testing, and a proposed booking is not a completed recollection.

Sources and scope

Updated on . This article combines the cited references with Bractis’s original workflow analysis and illustrative examples. Product capabilities depend on the configured scope. No independent clinical or legal review is claimed.

  • WHO LQSI: Sample acceptance and rejection criteria

    Official activity read 28 October 2026. General laboratory quality context, not current Indian accreditation criteria or a test-specific acceptance threshold. LQSI version 1.0 displays older ISO cross-references and software notices; no current-standard certification is inferred.

  • WHO LQSI: Sample rejection procedure and notification form

    Identity, specimen, requester, date and rejection-reason elements read directly 28 October 2026 despite software notices. The earlier toolkit route and handbook PDF timed out. R-74 and the communication record are original fictional examples, not a validated clinical protocol.

Try the workflow
with Bractis.

Follow a fictional rejected specimen through the patient call, charge clarification, linked recollection and eventual report review.

Request a clinic demo